Sugi Predict

Sugi Predict / Compounds / SCHEMBL4475799

SCHEMBL4475799

SCHEMBL4475799

Cc1c(C(=O)c2sc(Nc3ccc(C(=O)NC4CCOC4=O)cc3)c(C#N)c2N)cnn1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.47
▸ POLB P06746 2/20 0.47
▸ MAPT P10636 5/20 0.45
▸ GAA P10253 1/20 0.45
▸ HPGD P15428 2/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ ALOX12 P18054 1/20 0.42
▸ MAPK11 Q15759 3/20 0.38
▸ MAPK14 Q16539 3/20 0.38
▸ RAB9A P51151 4/20 0.38
▸ NPC1 O15118 3/20 0.36
▸ RIPK1 Q13546 1/20 0.36
▸ PKM P14618 2/20 0.36
▸ ROCK2 O75116 1/20 0.36
▸ NR3C1 P04150 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13638727 0.91 MAPK11 (0.41) HPGDMAPK11MAPK14RAB9ANPC1
SCHEMBL4481173 0.88 ALDH1A1 (0.41) ALDH1A1POLBMAPTGAAHPGD
SCHEMBL4468052 0.83 MAPT (0.48) ALDH1A1POLBMAPTGAAHPGD
SCHEMBL4477182 0.82 MAPT (0.51) ALDH1A1POLBMAPTGAAHPGD
SCHEMBL4471831 0.81 MAPT (0.48) ALDH1A1POLBMAPTGAAHPGD
SCHEMBL4474220 0.81 MAPT (0.46) ALDH1A1POLBMAPTGAAHPGD
SCHEMBL4476805 0.81 MAPT (0.46) ALDH1A1POLBMAPTGAAHPGD
SCHEMBL4461240 0.81 ALDH1A1 (0.47) ALDH1A1POLBMAPTGAAHPGD
SCHEMBL4479398 0.80 RAB9A (0.56) ALDH1A1POLBMAPTGAAHPGD
SCHEMBL4464981 0.80 MAPT (0.47) ALDH1A1POLBMAPTGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-20060041006-A1 PDE4B inhibitors and uses therefor PLEXXIKON, INC. 2006-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PDE4B, PDE7B, PDE4A ALDH1A1 802/4885POLB 248/4885MAPT 3524/4885
US-20060041006-A1 PDE4B inhibitors and uses therefor PDE4B, PDE7B, PDE4A ALDH1A1 802/4885POLB 248/4885MAPT 3524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.